- €85.21m
- €389.25m
- €83.53m
- 55
- 90
- 43
- 70
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 104 | 80.1 | 61.8 | 77.8 | 83.5 |
Cost of Revenue | |||||
Gross Profit | 20.8 | 29.2 | 8.7 | 20.1 | 23.5 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 90 | 60.7 | 115 | 65.6 | 70.8 |
Operating Profit | 14.3 | 19.4 | -53.2 | 12.2 | 12.7 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6 | 43.8 | -75.8 | -6.9 | 16 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.56 | 34 | -64 | -5.9 | 13.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 7.56 | 34 | -64 | -5.9 | 13.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.56 | 34 | -64 | -5.9 | 13.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.03 | 0.031 | -0.038 | 0.013 | 0.019 |
Dividends per Share |